スポンサーリンク
Department of Hematology and Oncology, Tokai University School of Medicine | 論文
- IDENTIFICATION OF ASTACIN-LIKE SQUID METALLOPROTEASE IN CUTTLEFISH, SEPIA ESCVLENTA(Taxonomy and Systematics,Abstracts of papers presented at the 76^ Annual Meeting of the Zoological Society of Japan)
- The Gelsolin/Fragmin Family Protein Identified in the Higher Plant Mimosa pudica
- Purification and Characterization of a Novel Isoform of Myosinase from Spear Squid Liver
- Distribution of Myosinase I and Myosinase II in Tissues of Coleoidea
- Clinical Effects of Infusing Anti-Epstein -Barr Virus (EBV)-Specific Cytotoxic T-Lymphocytes into Patients with Severe Chronic Active EBV Infection
- Comparison of Soluble and Membrane Bound HLA-Class I and DR Levels in Umbilical Cord Blood and Adult Peripheral Blood
- The Generation of Immunocompetent Dendritic Cells From CD34^+ Acute Myeloid or Lymphoid Leukemia Cells
- The Impact of HLA-A Matching in Corneal Transplantation
- Autografting with peripheral blood CD34-positive cells following high-dose chemotherapy against breast cancer
- Cloning and Biochemical Characterization of Astacin-Like Squid Metalloprotease
- Effects of additives on the thermal gelation of Japanese common squid natural actomyosin
- Studies on Thermal Denaturation of Fish Myoglobins using Differential Scanning Calorimetry, Circular Dichroism, and Tryptophan Fluorescence
- Change in the Actin Cytoskeleton during Seismonastic Movement of Mimosa pudica
- Balloon-endoscopic retrograde pancreatography employed for extracorporeal shockwave pancreatic lithotripsy
- Characteristics of CD5-Positive Splenic Marginal Zone Lymphoma with Leukemic Manifestation ; Clinical, Flow Cytometry, and Histopathological Findings of 11 Cases
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results